Article
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.
Journal of infection and public health - 1 Feb 2022
Malik Jonaid Ahmad, Ahmed Sakeel, Mir Aroosa, Shinde Mrunal, Bender Onur, Alshammari Farhan, Ansari Mukhtar, Anwar Sirajudheen
Abstract excerpt
BACKGROUND: The SARS-CoV-2 coronavirus epidemic is hastening the discovery of the most efficient vaccines. The development of cost-effective vaccines seems to be the only solution to terminate this pandemic. However, the vaccines' effectiveness has been questioned due to recurrent mutations in the SARS-CoV-2 genome. Most of the mutations are associated with the spike protein, a vital target for several marketed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
